Finance

Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs

Feb 7, 2025 - 09:57
 0
Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs
Read More

Tags:

Previous Article

Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected.

Next Article

Jet Maker Embraer Scores Breakout On Record $7 Billion Order

Related Posts

Advanced Micro Devices, Inc. (AMD) Q4 2024 Earnings Cal...

Feb 5, 2025  0

Bancolombia: Undervalued With Potential Catalyst

Feb 5, 2025  0

Check Point Software: Downgrade To Hold On High Valuation And Near-Term Concerns

Check Point Software: Downgrade To Hold On High Valuati...

Feb 6, 2025  0